Engineering and Development

Customer Service and Support

Management and Executive

Product Management

Sales

Marketing

Accounting and Finance

Chief Commercial Officer (CCO)

Veracyte initiated with neutral view at Canaccord, here's why

Freedom Capital Markets Initiates Coverage of Veracyte With Buy Rating and $45 Price Target

Veracyte to Release Third Quarter 2025 Financial Results on November 4, 2025

Veracyte Insider Sold Shares Worth $753,204, According to a Recent SEC Filing

Clinical Data Manager

Veracyte is a global genomic diagnostics company committed to transforming cancer care for patients. The Clinical Data Manager will oversee all aspects of Clinical Data Management Operations, ensuring data integrity and quality for clinical studies while collaborating with various teams to establish data collection methods and quality standards.

Clinical Data Management

Vice President, Employment Law & Global HR

Sr Director, Total Rewards

Sign up with Google

Sign in with Google